Industry leaders such as copyright, Novartis, Roche, Astellas, and Fujifilm are intensifying investments in regenerative medicine pipelines and CDMO capabilities https://www.einpresswire.com/article/833510964/cell-regeneration-medicine-market-poised-for-breakthrough-growth-datam-intelligence